Aparajita Praharaj De
Dr. Aparajita Praharaj De is a dental specialist and digital medical strategist with 10+ years of professional experience, including over three years in the pharmaceutical industry with Bayer. She currently serves as a Digital Medical Science Liaison in the Cardio-Renal-Metabolic (CKM) therapy area and as a Global Oncology Social Media and Digital Content Strategist under Bayer’s Patient & Scientific Engagement (PSE) sub-cluster. Blending a strong scientific foundation with expertise in digital innovation and AI, she focuses on building transformative engagement models that connect science, storytelling, and strategy across therapeutic areas.
Work Experience:
10 Years
Industry:
Function:
Bayer AG
- Aparajita began her professional journey as a General Dental Surgeon before joining the Government Dental College and Hospital Mumbai as a Specialist Dental Surgeon and Lecturer in Oral Medicine and Radiology During this time she contributed to oral oncology diagnostics academic training and research initiatives
- Since 2021 she has been associated with Bayer India initially as a Field Medical Science Liaison supporting the prelaunch and launch phases of Finerenone In her current role as Digital MSL she leads panIndia omnichannel medical engagement driving meaningful scientific interactions through innovative digital platforms
- In addition to her India responsibilities Aparajita has been appointed to a Global Assignment as Oncology Social Media and Digital Content Strategist under Bayers Global Medical Affairs PSE team She collaborates with global and regional leads to shape content strategy across Bayers oncology portfolio Her work spans campaign ideation crossfunctional coordination socialmedia toolkits and AIenabled engagement frameworks for global congresses such as ESMO EANM etc
- Her contributions to digital medical transformation AIdriven content systems CORTEX and global collaboration have earned recognition across the organization including APAC Top 3 in Digital Innovation 2023 and Top 3 at CMO Awards 2024